Why the study?
Does primary percutaneous coronary intervention improve survival compared to in-hospital fibrinolytic therapy in patients with ST-segment elevation acute myocardial infarction?
Does primary percutaneous coronary intervention improve survival compared to in-hospital fibrinolytic therapy in patients with ST-segment elevation acute myocardial infarction?
Primary PCI is the preferred reperfusion strategy for STEMI over fibrinolysis, provided the PCI-related delay does not exceed acceptable guideline-recommended timeframes.
Primary percutaneous coronary intervention (PCI) is abetter reperfusion therapy for ST-segment elevation acutemyocardial infarction than in-hospital fibrinolytic therapy when it is performed soon after the onset of symptoms by an experienced team. Both the American and the European guide-lines for the management of ST-segment elevation acute myo-cardial infarction recommend that the procedure should be done within 90 minutes of presentation.1,2 Although delays in the delivery of both fibrinolytic therapy and primary PCI are associated with increased mortality rates, an extra (unavoidable) delay of up to 60 minutes is considered to be acceptable for primary PCI because this reperfusion treatment is associated with higher patency rates of the infarct vessel and better survival when compared with fibrinolytic therapy. This “PCI-related delay ” is usually presented as the “door-to-balloon ” time minus the “door-to-needle ” time. The guidelines recommend a “door-to-needle ” time of 30 minutes and, as mentioned above, the
No takes yet. Share an insight, caveat, or question.
Frans Van de Werf (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: